PLA2R1 anticorps (C-Term)

N° du produit ABIN347711

Cet anticorps anti-PLA2R1 est un anticorps Lapin Polyclonal détectant PLA2R1 dans WB, ELISA, IHC et IF. Adapté pour Humain. Ce Primary Antibody a été cité dans 1 publication.

Aperçu rapide pour PLA2R1 anticorps (C-Term) (ABIN347711)

Antigène: PLA2R1 (phospholipase A2 Receptor 1, 180kDa (PLA2R1))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp PLA2R1 est non-conjugé

Application: Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)

Détail du produit anti-PLA2R1 anticorps

Épitope: C-Term

Specificité: Reacts with human PLA2R

Purification: Antiserum

Immunogène: Synthetic peptide derived from Cter domain of human PLA2R

Isotype: IgG

Information d'application

Indications d'application:

Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only :
IHC(1:100 - 1:500) WB (1:500 - 1:5000)

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Reconstitution: Must be reconstituted in distilled water.

Stock: 4 °C/-20 °C

Stockage commentaire: Lyophilized powder stable for a minimum of 2 years at -20°C. Store reconstituted antibodies at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt.

Date de péremption: 24 months

Références pour anticorps anti-PLA2R1 (ABIN347711)

Hoxha, Harendza, Zahner, Panzer, Steinmetz, Fechner, Helmchen, Stahl: "An immunofluorescence test for phospholipase-A2-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis." dans: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, (2011) (PubMed).

Détails sur PLA2R1

Antigène: PLA2R1 (phospholipase A2 Receptor 1, 180kDa (PLA2R1))

Autre désignation: Secretory Phospholipase A2 Receptor (PLA2R)

Sujet: Receptor of phospholipase A2 IB (G1B) but not IIA (G2A).

ID gène: 22925

UniProt: Q13018

Pathways: Positive Regulation of Response to DNA Damage Stimulus